
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8290309
[patent_doc_number] => 20120178637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'BIOMARKERS AND METHODS FOR DETECTING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/919469
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 19336
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12919469
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919469 | BIOMARKERS AND METHODS FOR DETECTING ALZHEIMER'S DISEASE | Jul 6, 2010 | Abandoned |
Array
(
[id] => 6135174
[patent_doc_number] => 20110008872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Immortalized Avian Cell Lines'
[patent_app_type] => utility
[patent_app_number] => 12/829773
[patent_app_country] => US
[patent_app_date] => 2010-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12738
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008872.pdf
[firstpage_image] =>[orig_patent_app_number] => 12829773
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/829773 | Immortalized avian cell lines | Jul 1, 2010 | Issued |
Array
(
[id] => 6097312
[patent_doc_number] => 20110003708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'BIOMARKERS FOR THE PREDICTION OF RENAL INJURY'
[patent_app_type] => utility
[patent_app_number] => 12/824010
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 50666
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003708.pdf
[firstpage_image] =>[orig_patent_app_number] => 12824010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/824010 | BIOMARKERS FOR THE PREDICTION OF RENAL INJURY | Jun 24, 2010 | Abandoned |
Array
(
[id] => 8160047
[patent_doc_number] => 20120101005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'METHODS FOR PREDICTING THE TOXICITY OF A CHEMICAL'
[patent_app_type] => utility
[patent_app_number] => 13/380195
[patent_app_country] => US
[patent_app_date] => 2010-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18104
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101005.pdf
[firstpage_image] =>[orig_patent_app_number] => 13380195
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/380195 | METHODS FOR PREDICTING THE TOXICITY OF A CHEMICAL | Jun 22, 2010 | Abandoned |
Array
(
[id] => 6102181
[patent_doc_number] => 20110165674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'NK-1 Receptor Mediated Delivery of Agents to Cells'
[patent_app_type] => utility
[patent_app_number] => 12/797137
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7575
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12797137
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797137 | NK-1 Receptor Mediated Delivery of Agents to Cells | Jun 8, 2010 | Abandoned |
Array
(
[id] => 6387028
[patent_doc_number] => 20100317533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'BIOMARKERS OF CANCER METASTASIS'
[patent_app_type] => utility
[patent_app_number] => 12/795269
[patent_app_country] => US
[patent_app_date] => 2010-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16077
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317533.pdf
[firstpage_image] =>[orig_patent_app_number] => 12795269
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/795269 | BIOMARKERS OF CANCER METASTASIS | Jun 6, 2010 | Abandoned |
Array
(
[id] => 9074591
[patent_doc_number] => 08552170
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Expression vector for establishing highly productive cell and the highly productive cell'
[patent_app_type] => utility
[patent_app_number] => 13/122119
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 63
[patent_figures_cnt] => 77
[patent_no_of_words] => 37536
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122119
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122119 | Expression vector for establishing highly productive cell and the highly productive cell | Jun 3, 2010 | Issued |
Array
(
[id] => 11894124
[patent_doc_number] => 09764044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Homologous recombination in multipotent adult progenitor cells'
[patent_app_type] => utility
[patent_app_number] => 12/784579
[patent_app_country] => US
[patent_app_date] => 2010-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20142
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12784579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/784579 | Homologous recombination in multipotent adult progenitor cells | May 20, 2010 | Issued |
Array
(
[id] => 8220778
[patent_doc_number] => 20120134983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'Method for Identifying Interventions that Control the Translational Activity of Ribosomal Proteins in Different MRNA Expression'
[patent_app_type] => utility
[patent_app_number] => 13/320172
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14925
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320172
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320172 | Method for identifying interventions that control the translational activity of ribosomal proteins in differential mRNA expression | May 11, 2010 | Issued |
Array
(
[id] => 7586771
[patent_doc_number] => 20110281281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'INTEGRATION-FREE HUMAN INDUCED PLURIPOTENT STEM CELLS FROM BLOOD'
[patent_app_type] => utility
[patent_app_number] => 12/778938
[patent_app_country] => US
[patent_app_date] => 2010-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12854
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281281.pdf
[firstpage_image] =>[orig_patent_app_number] => 12778938
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/778938 | Integration-free human induced pluripotent stem cells from blood | May 11, 2010 | Issued |
Array
(
[id] => 5953151
[patent_doc_number] => 20110033853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'CSNKS As Modifiers of the RAC Pathway and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/774692
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15705
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033853.pdf
[firstpage_image] =>[orig_patent_app_number] => 12774692
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/774692 | CSNKS As Modifiers of the RAC Pathway and Methods of Use | May 4, 2010 | Abandoned |
Array
(
[id] => 6320679
[patent_doc_number] => 20100196401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'USE OF RAPAMYCIN TO INHIBIT IMMUNE RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 12/761310
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7317
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196401.pdf
[firstpage_image] =>[orig_patent_app_number] => 12761310
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/761310 | USE OF RAPAMYCIN TO INHIBIT IMMUNE RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS | Apr 14, 2010 | Abandoned |
Array
(
[id] => 10554931
[patent_doc_number] => 09279129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Mutant AOX1 promoters'
[patent_app_type] => utility
[patent_app_number] => 12/759763
[patent_app_country] => US
[patent_app_date] => 2010-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24651
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12759763
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759763 | Mutant AOX1 promoters | Apr 13, 2010 | Issued |
Array
(
[id] => 6487765
[patent_doc_number] => 20100285592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'SINGLE EXPRESSION VECTOR FOR GENERATION OF A VIRUS WITH A SEGMENTED GENOME'
[patent_app_type] => utility
[patent_app_number] => 12/759842
[patent_app_country] => US
[patent_app_date] => 2010-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25826
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285592.pdf
[firstpage_image] =>[orig_patent_app_number] => 12759842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759842 | Single expression vector for generation of a virus with a segmented genome | Apr 13, 2010 | Issued |
Array
(
[id] => 6510843
[patent_doc_number] => 20100261227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Production of Proteins Using Transposon-Based Vectors'
[patent_app_type] => utility
[patent_app_number] => 12/757591
[patent_app_country] => US
[patent_app_date] => 2010-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 42007
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261227.pdf
[firstpage_image] =>[orig_patent_app_number] => 12757591
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/757591 | Production of proteins using transposon-based vectors | Apr 8, 2010 | Issued |
Array
(
[id] => 7756511
[patent_doc_number] => 20120028816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'METHODS AND SYSTEMS FOR SCREENING FOR AND DIAGNOSING DNA METHYLATION ASSOCIATED WITH AUTISM SPECTRUM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/260836
[patent_app_country] => US
[patent_app_date] => 2010-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33234
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028816.pdf
[firstpage_image] =>[orig_patent_app_number] => 13260836
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260836 | METHODS AND SYSTEMS FOR SCREENING FOR AND DIAGNOSING DNA METHYLATION ASSOCIATED WITH AUTISM SPECTRUM DISORDERS | Mar 30, 2010 | Abandoned |
Array
(
[id] => 10346221
[patent_doc_number] => 20150231227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 12/749164
[patent_app_country] => US
[patent_app_date] => 2010-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 76
[patent_no_of_words] => 29378
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12749164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/749164 | COMPOSITIONS AND METHODS FOR GENERATING AN IMMUNE RESPONSE | Mar 28, 2010 | Abandoned |
Array
(
[id] => 7767801
[patent_doc_number] => 20120035079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'GENOTOXICITY TESTING'
[patent_app_type] => utility
[patent_app_number] => 13/260458
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15561
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035079.pdf
[firstpage_image] =>[orig_patent_app_number] => 13260458
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/260458 | GENOTOXICITY TESTING | Mar 25, 2010 | Abandoned |
Array
(
[id] => 7696686
[patent_doc_number] => 20110229904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'RECOMBINANT CONSTRUCT FOR DETECTION OF HALOGENATED AROMATIC HYDROCARBONS'
[patent_app_type] => utility
[patent_app_number] => 12/726099
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3545
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229904.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726099 | Recombinant construct for detection of halogenated aromatic hydrocarbons | Mar 16, 2010 | Issued |
Array
(
[id] => 8629719
[patent_doc_number] => 08361789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Cells useful for immuno-based Botulinum toxin serotype A activity assays'
[patent_app_type] => utility
[patent_app_number] => 12/722801
[patent_app_country] => US
[patent_app_date] => 2010-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 66969
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12722801
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/722801 | Cells useful for immuno-based Botulinum toxin serotype A activity assays | Mar 11, 2010 | Issued |